| Name |
Recombinant Human C1qTNF14/C1qL1, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9134-TN
|
| Category |
Protein
|
| Prices |
$329.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
E. coli -derived Thr125-Asp258, with an N-terminal Met and 6-His tag
|
| Purity |
>85%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its binding ability in a functional ELISA. When Recombinant Human C1qTNF14/C1qL1 is immobilized at 1 μg/mL, 100 μL/well, the concentration of Recombinant Human BAI3 (Catalog # 9106-BA ) that produces 50% of the optimal binding response is approximately 0.4-2.4 μg/mL
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
O75973
|
| Gene |
C1QL1
|
| Sequence |
Met
|
| Supplier Page |
Shop
|
When Recombinant Human C1qTNF14/C1qL1 (Catalog # 9134-TN) is coated at 1 µg/mL (100 μL/well), Recombinant Human BAI3 (Catalog # (Catalog # 9106-BA ) binds with a typical ED 50 of 0.4-2.4 μg/mL.